A Randomized, Double-blind, Active-comparator, 8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects.

Trial Profile

A Randomized, Double-blind, Active-comparator, 8-week Forced-titration Study of the Efficacy and Safety of Olmesartan Medoxomil Versus Losartan Potassium in Hypertensive Subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Losartan; Olmesartan medoxomil
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms BeniVICTOR
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 01 Jan 2011 Results were published in the Journal of Postgraduate Medicine.
    • 01 Oct 2010 Results were presented in a late breaker session at the 23rd Scientific Meeting of the International Society of Hypertension (ISH).
    • 01 Oct 2010 Trial acronym and long name added, as reported in a Daiichi Sankyo media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top